An Updated Comparison Between World Health Organization Grade II Gemistocytic and Diffuse Astrocytoma Survival and Treatment Patterns.
Rodrigues A, Zhang M, Toland A, Bhambhvani H, Hayden-Gephart M.
World Neurosurg. 2022 Feb;158:e903-e913. doi: 10.1016/j.wneu.2021.11.089. Epub 2021 Nov 27.
PMID:34844008
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma.
van Hijfte L, Geurts M, de Heer I, Ghisai SA, Balcioglu HE, Hoogstrate Y, Vallentgoed WR, Head R, Luning R, van den Bosch T, Westerman B, Wesseling P, Joyce JA, French P, Debets R.
Nat Commun. 2025 Jan 29;16(1):1156. doi: 10.1038/s41467-025-56441-5.
PMID:39880824
Magnetic resonance imaging features of gemistocytic astrocytoma.
Simkin PM, Yang N, Tsui A, Kalnins RM, Fitt G, Gaillard F.
J Med Imaging Radiat Oncol. 2016 Dec;60(6):733-740. doi: 10.1111/1754-9485.12550. Epub 2016 Oct 21.
PMID:27766769
Astrocytoma: A Hormone-Sensitive Tumor?
Hirtz A, Rech F, Dubois-Pot-Schneider H, Dumond H.
Int J Mol Sci. 2020 Nov 30;21(23):9114. doi: 10.3390/ijms21239114.
PMID:33266110
Prognostic relevance of gemistocytic grade II astrocytoma: gemistocytic component and MR imaging features compared to non-gemistocytic grade II astrocytoma.
Heo YJ, Park JE, Kim HS, Lee JY, Nam SJ, Jung SC, Choi CG, Kim SJ.
Eur Radiol. 2017 Jul;27(7):3022-3032. doi: 10.1007/s00330-016-4649-z. Epub 2016 Nov 17.